Circulating free soluble fms-like tyrosine kinase-1 during late first trimester in relation with placental volume as a surrogate for trophoblastic production: a physiology study in low-risk cohort

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 30, Issue 16, 2017, Pages 1976-1983

  Manthati, Sudtawin ^a   Pratumvinit, Busadee ^a   Hanyongyuth, Ratchaneekorn ^a   Udompunthurak, Suthipol ^a   Phaophan, Amprapha ^a   Wataganara, Tuangsit ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Free sFlt 1; placental volume; preeclampsia; serum biomarker

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLYCOPROTEIN; VASCULOTROPIN; FLT1 PROTEIN, HUMAN; VASCULOTROPIN RECEPTOR 1;

ARTICLE; AUTOMATION; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; CROWN RUMP LENGTH; DOPPLER FLOWMETRY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTION; TROPHOBLAST; UTERINE ARTERY; ADULT; BIOSYNTHESIS; BLOOD; DIAGNOSTIC IMAGING; METABOLISM; ORGAN SIZE; PLACENTA; PREGNANCY; YOUNG ADULT;

ADULT; COHORT STUDIES; FEMALE; HUMANS; ORGAN SIZE; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 85011636600     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767058.2016.1235697     Document Type: Article

References (42)

1. Chappell JC, Taylor SM, Ferrara N, Bautch VL., Local guidance of emerging vessel sprouts requires soluble Flt-1. Dev Cell 2009;17:377–86
2. Hornig C, Barleon B, Ahmad S, et al. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest 2000;80:443–54
3. Vuorela P, Lintula S, Stenman UH, Halmesmaki E., Expression of vascular endothelial growth factor in peripheral blood cells of preeclamptic women. Hypertens Pregnancy 2003;22:193–201
4. Ahmed A, Dunk C, Ahmad S, Khaliq A., Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen–a review. Placenta 2000;21 Suppl A:S16–24
5. Reddy A, Suri S, Sargent IL, et al. Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia. PloS One 2009;4:e4453
6. Ananth CV., Ischemic placental disease:a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption. Semin Perinatol 2014;38:131–2
7. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
8. Thadhani R, Kisner T, Hagmann H, et al. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 2011;124:940–50
9. Murakami Y, Kobayashi T, Omatsu K, et al. Exogenous vascular endothelial growth factor can induce preeclampsia-like symptoms in pregnant mice. Semin Thromb Hemost 2005;31:307–13
10. Verlohren S, Galindo A, Schlembach D, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010;202:161 e1–e11
11. Olmos CS, Macedo MA, Pereira RM, et al. PP176. SFLT-1:a possibility of precocious diagnosis of preeclampsia. Pregnancy Hypertens 2012;2:335–6
12. Gomez-Arriaga PI, Herraiz I, Lopez-Jimenez EA, et al. Uterine artery Doppler and sFlt-1/PlGF ratio:prognostic value in early-onset pre-eclampsia. Ultrasound Obstet Gynecol 2014;43:525–32
13. Liu Z, Afink GB, Dijke PT., Soluble fms-like tyrosine kinase 1 and soluble endoglin are elevated circulating anti-angiogenic factors in pre-eclampsia. Pregnancy Hypertens 2012;2:358–67
14. Baumann MU, Bersinger NA, Mohaupt MG, et al. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 2008;199:266 e1
15. Powers RW, Roberts JM, Cooper KM, et al. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am J Obstet Gynecol 2005;193:185–91
16. Diguisto C, Piver E, Le Gouge A, et al. First trimester uterine artery Doppler, sFlt-1 and PlGF to predict preeclampsia in a high-risk population. J Matern Fetal Neonatal Med 2016;6:1–17
17. Triunfo S, Crovetto F, Rodriguez-Sureda V, et al. Changes in uterine artery Doppler velocimetry and circulating angiogenic factors in the first half of pregnancies delivering small-for-gestational age neonates. Ultrasound Obstet Gynecol 2016. [Epub ahead of print]. doi:10.1002/uog.15978
18. Whittaker PG, Lind T., The intravascular mass of albumin during human pregnancy:a serial study in normal and diabetic women. BJOG 1993;100:587–92
19. Schneuer FJ, Nassar N, Guilbert C, et al. First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy. Pregnancy Hypertens 2013;3:215–21
20. Smith GC, Crossley JA, Aitken DA, et al. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol 2007;109:1316–24
21. Young BC, Karumanchi SA., Toward a better diagnosis for preeclampsia. Clin Chem 2016;62:913–5
22. Andersen LB, Frederiksen-Moller B, Work Havelund K, et al. Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio:an inter-assay comparison. JASH 2015;9:86–96
23. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R., Pre-eclampsia part 1:current understanding of its pathophysiology. Nat Rev Nephrol 2014;10:466–80
24. Khalil A, Nicolaides KH., How to record uterine artery Doppler in the first trimester. Ultrasound Obstet Gynecol 2013;42:478–9
25. Wataganara T, Metzenbauer M, Peter I, et al. Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA. Am J Obstet Gynecol 2005;193:496–500
26. Napolitano R, Rajakulasingam R, Memmo A, et al. Uterine artery Doppler screening for pre-eclampsia:comparison of the lower, mean and higher first-trimester pulsatility indices. Ultrasound Obstet Gynecol 2011;37:534–7
27. Maynard SE, Moore Simas TA, Solitro MJ, et al. Circulating angiogenic factors in singleton vs multiple-gestation pregnancies. Am J Obstet Gynecol 2008;198:200 e1–7
28. Bdolah Y, Lam C, Rajakumar A, et al. Twin pregnancy and the risk of preeclampsia:bigger placenta or relative ischemia?. Am J Obstet Gynecol 2008;198:428 e1–6
29. Staff AC, Braekke K, Harsem NK, et al. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005;122:33–9
30. Barleon B, Reusch P, Totzke F, et al. Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors. Angiogenesis 2001;4:143–54
31. Felmeden DC, Spencer CG, Belgore FM, et al. Endothelial damage and angiogenesis in hypertensive patients:relationship to cardiovascular risk factors and risk factor management. Am J Hypertens 2003;16:11–20
32. Bujold E, Effendi M, Girard M, et al. Reproducibility of first trimester three-dimensional placental measurements in the evaluation of early placental insufficiency. J Obstet Gynaecol Can 2009;31:1144–8
33. Craven CM, Ward K., Syncytiotrophoblastic fragments in first-trimester decidual veins:evidence of placental perfusion by the maternal circulation early in pregnancy. Am J Obstet Gynecol 1999;181:455–9
34. Bower C, Stanley F, Walters BN., Pre-eclampsia and trisomy 13. Lancet 1987;2:1032
35. Bdolah Y, Palomaki GE, Yaron Y, et al. Circulating angiogenic proteins in trisomy 13. Am J Obstet Gynecol 2006;194:239–45
36. Qumsiyeh MB, Kim KR, Ahmed MN, Bradford W., Cytogenetics and mechanisms of spontaneous abortions:increased apoptosis and decreased cell proliferation in chromosomally abnormal villi. Cytogenet Genome Res 2000;88:230–5
37. Purde MT, Baumann M, Wiedemann U, et al. Incidence of preeclampsia in pregnant Swiss women. Swiss Med Wkly 2015;145:w14175
38. Lisonkova S, Sabr Y, Mayer C, et al. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol 2014;124:771–81
39. Wataganara T, LeShane ES, Farina A, et al. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Hum Genet 2003;112:204–8
40. Wataganara T, Gratacos E, Jani J, et al. Persistent elevation of cell-free fetal DNA levels in maternal plasma after selective laser coagulation of chorionic plate anastomoses in severe midgestational twin-twin transfusion syndrome. Am J Obstet Gynecol 2005;192:604–9
41. Valentin L, Sladkevicius P, Laurini R, et al. Uteroplacental and luteal circulation in normal first-trimester pregnancies:Doppler ultrasonographic and morphologic study. Am J Obstet Gynecol 1996;174:768–75
42. Committee Opinion No. 638:First-trimester risk assessment for early-onset preeclampsia. Obstet Gynecol 2015;126:e25–7